Type | Modality | Positive/Tested |
| HBsAg | 24.11% (34/141) |
| AcAntiHBs | 4.76% (1/21) |
| AgHBe | 16.67% (2/12) |
HBV |
|
|
| AcAntiHBe | 75% (3/4) |
| AcAntiHBc | 30.77% (8/26) |
| viral DNA | 60% (3/5) |
| AcAntiHCV | 2.26% (2/78) |
HCV |
|
|
| viral RNA | None |